Online games may help people with MS

A new collaboration by doctors and computer specialists has produced a series of online games that its creators say help people with multiple sclerosis.

Drugmakers pour $40 million into healthcare reform debate

Statistics show that the Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying group that represents 32 brandname drug companies, and its member companies have spent $40 million lobbying Congress as the lawmakers work to overhaul the U.S. healthcare system.

How to help a partner in chronic pain

Researchers have found that in couples living with chronic pain, the person who isn’t dealing with pain may be invalidating the feelings of a person who is, and this can lead to less intimacy in the relationship.

Smoking may speed multiple sclerosis

New research published in the Archives of Neurology has found that multiple sclerosis (MS) patients who smoke experience a faster progression of the disease.

Doctors judge patients by their looks, studies show

Several studies have found that doctors treat patients differently depending on their race and body weight.

Reid: No healthcare vote until after August recess

Senate Majority Leader Harry Reid says there will be no vote on healthcare reform before Congress takes its August break, a move that would go against President Obama’s announced timetable for its vote.

AMA backs House healthcare reform bill

The American Medical Association (AMA) is urging approval for healthcare overhaul legislation currently moving through committees in the U.S. House of Representatives.

House bill would make health care a ‘right, responsibility’

Democrats in the U.S. House of Representatives want to define health care as a right and a responsibility for all Americans.

Surgeon General choice will put primary care at the forefront

Dr. Regina Benjamin, President Obama’s choice for Surgeon General, puts the face of primary care at the forefront of the Obama administration’s healthcare reform efforts, experts say.

New MS drug ‘fast-tracked’ by FDA

The FDA’s fast-track designation is “designed to expedite the review of new drugs that are intended to treat serious or life-threatening conditions and demonstrate the potential to address unmet medical needs.”

« Previous Entries